Daewon Pharmaceutical Co. Ltd. (003220) — Financial Flexibility Index
Daewon Pharmaceutical Co. Ltd. (003220) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of ₩-233.57 Million (operating CF ₩-4.39 Billion minus capex ₩4.15 Billion) represents 0% of total liabilities (₩297.60 Billion). Explore 003220 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daewon Pharmaceutical Co. Ltd. Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Daewon Pharmaceutical Co. Ltd. across 15 annual periods. Check 003220 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for Daewon Pharmaceutical Co. Ltd. (2011–2025)
Year-by-year free cash flow to debt coverage for Daewon Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see how efficiently does Daewon Pharmaceutical Co. Ltd. generate cash.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | ₩84.44 Billion | ₩42.31 Billion | ₩339.07 Billion | ▼ -11.0% |
| 2024 | 0.28x | ₩83.62 Billion | ₩30.04 Billion | ₩298.81 Billion | ▼ -5.7% |
| 2023 | 0.30x | ₩72.34 Billion | ₩51.73 Billion | ₩243.73 Billion | ▲ +30.2% |
| 2022 | 0.23x | ₩46.69 Billion | ₩33.33 Billion | ₩204.78 Billion | ▲ +81.6% |
| 2021 | 0.13x | ₩26.52 Billion | ₩22.41 Billion | ₩211.18 Billion | ▼ -57.6% |
| 2020 | 0.30x | ₩36.30 Billion | ₩24.95 Billion | ₩122.44 Billion | ▼ -42.9% |
| 2019 | 0.52x | ₩64.00 Billion | ₩30.97 Billion | ₩123.32 Billion | ▼ -40.8% |
| 2018 | 0.88x | ₩80.85 Billion | ₩40.03 Billion | ₩92.24 Billion | ▲ +172.9% |
| 2017 | 0.32x | ₩18.98 Billion | ₩4.27 Billion | ₩59.07 Billion | ▼ -59.1% |
| 2016 | 0.79x | ₩41.36 Billion | ₩20.79 Billion | ₩52.67 Billion | ▼ -20.7% |
| 2015 | 0.99x | ₩45.62 Billion | ₩25.82 Billion | ₩46.09 Billion | ▲ +37.1% |
| 2014 | 0.72x | ₩33.28 Billion | ₩17.45 Billion | ₩46.11 Billion | ▲ +20.1% |
| 2013 | 0.60x | ₩22.17 Billion | ₩12.32 Billion | ₩36.89 Billion | ▲ +20.0% |
| 2012 | 0.50x | ₩17.13 Billion | ₩13.83 Billion | ₩34.20 Billion | ▼ -35.0% |
| 2011 | 0.77x | ₩28.12 Billion | ₩17.93 Billion | ₩36.47 Billion | — |